3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Magnetic Resonance Spectroscopy
3
Biopsy
3
fludarabine
2
Taxes
2
Paclitaxel
2
Endoscopic Mucosal Resection
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
venetoclax
1
trametinib
1
toripalimab
1
thymoglobulin
1
taxane
1
sintilimab
1
potassium oxonate
1
lutetium Lu 177 dotatate
1
gimeracil
1
fludarabine phosphate
1
dabrafenib
1
apatinib
1
Whole-Body Irradiation
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Tegafur
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Standard of Care
1
Specimen Handling
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Acetic Acid
×
Other neoplasm
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled